Literature DB >> 10347146

Functional interaction between the N- and C-terminal halves of human hexokinase II.

H Ardehali1, R L Printz, R R Whitesell, J M May, D K Granner.   

Abstract

Mammalian hexokinases (HKs) I-III are composed of two highly homologous approximately 50-kDa halves. Studies of HKI indicate that the C-terminal half of the molecule is active and is sensitive to inhibition by glucose 6-phosphate (G6P), whereas the N-terminal half binds G6P but is devoid of catalytic activity. In contrast, both the N- and C-terminal halves of HKII (N-HKII and C-HKII, respectively) are catalytically active, and when expressed as discrete proteins both are inhibited by G6P. However, C-HKII has a significantly higher Ki for G6P (KiG6P) than N-HKII. We here address the question of whether the high KiG6P of the C-terminal half (C-half) of HKII is decreased by interaction with the N-terminal half (N-half) in the context of the intact enzyme. A chimeric protein consisting of the N-half of HKI and the C-half of HKII was prepared. Because the N-half of HKI is unable to phosphorylate glucose, the catalytic activity of this chimeric enzyme depends entirely on the C-HKII component. The KiG6P of this chimeric enzyme is similar to that of HKI and is significantly lower than that of C-HKII. When a conserved amino acid (Asp209) required for glucose binding is mutated in the N-half of this chimeric protein, a significantly higher KiG6P (similar to that of C-HKII) is observed. However, mutation of a second conserved amino acid (Ser155), also involved in catalysis but not required for glucose binding, does not increase the KiG6P of the chimeric enzyme. This resembles the behavior of HKII, in which a D209A mutation results in an increase in the KiG6P of the enzyme, whereas a S155A mutation does not. These results suggest an interaction in which glucose binding by the N-half causes the activity of the C-half to be regulated by significantly lower concentrations of G6P.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10347146     DOI: 10.1074/jbc.274.23.15986

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy.

Authors:  D J Roberts; S Miyamoto
Journal:  Cell Death Differ       Date:  2014-10-17       Impact factor: 15.828

2.  Regulation and cytoprotective role of hexokinase III.

Authors:  Eugene Wyatt; Rongxue Wu; Wael Rabeh; Hee-Won Park; Mohsen Ghanefar; Hossein Ardehali
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

3.  Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II.

Authors:  Lin Sun; Shetha Shukair; Tejaswitha Jairaj Naik; Farzad Moazed; Hossein Ardehali
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

Review 4.  Hexokinase-mitochondrial interaction in cardiac tissue: implications for cardiac glucose uptake, the 18FDG lumped constant and cardiac protection.

Authors:  Richard Southworth
Journal:  J Bioenerg Biomembr       Date:  2009-04       Impact factor: 2.945

5.  Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production.

Authors:  Rongxue Wu; Eugene Wyatt; Kusum Chawla; Minh Tran; Mohsen Ghanefar; Markku Laakso; Conrad L Epting; Hossein Ardehali
Journal:  EMBO Mol Med       Date:  2012-04-20       Impact factor: 12.137

Review 6.  Key stages in mammary gland development. Secretory activation in the mammary gland: it's not just about milk protein synthesis!

Authors:  Steven M Anderson; Michael C Rudolph; James L McManaman; Margaret C Neville
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

7.  Akt phosphorylates HK-II at Thr-473 and increases mitochondrial HK-II association to protect cardiomyocytes.

Authors:  David J Roberts; Valerie P Tan-Sah; Jeffery M Smith; Shigeki Miyamoto
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

8.  The catalytic inactivation of the N-half of human hexokinase 2 and structural and biochemical characterization of its mitochondrial conformation.

Authors:  Mir Hussain Nawaz; Juliana C Ferreira; Lyudmila Nedyalkova; Haizhong Zhu; César Carrasco-López; Serdal Kirmizialtin; Wael M Rabeh
Journal:  Biosci Rep       Date:  2018-02-21       Impact factor: 3.840

9.  Dissociation of HKII in retinal epithelial cells induces oxidative stress injury in the retina.

Authors:  Liqun Chu; Lin Xiao; Bing Xu; Jingmei Xu
Journal:  Int J Mol Med       Date:  2019-08-06       Impact factor: 4.101

10.  Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death.

Authors:  R L Aft; F W Zhang; D Gius
Journal:  Br J Cancer       Date:  2002-09-23       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.